Details Overview Explorer

Determination of Regulatory Review Period for Purposes of Patent Extension; BLUJEPA

FDA-2025-E-2426-0006Notice

Comments

0

Awaiting comments

Deadline

27 days

Closes Aug 13, 2026

Net supporti

—

Document

Details

The document's own metadata, straight from the source system.

Title: Determination of Regulatory Review Period for Purposes of Patent Extension; BLUJEPA

Posted: Feb 13, 2026
Comment period: Feb 13, 2026 – Aug 13, 2026
Agency: Food and Drug Administration (FDA)
FR Doc: 2026-02901
Topics: Pharmaceutical Policy

View on regulations.gov ↗

Analysis

Overview

No comments yet — comment period open · 27 days left.

Comments

Explorer

Every mirrored comment — filter by stance, campaign, or issue.

Filter:

No comments match.